These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38720210)

  • 1. Effect of Intense Pulsed Light versus Intradermal Tranexamic Acid for the Management of Melasma.
    Asim SA; Iqbal T; Sajid M; Bhatti S
    J Coll Physicians Surg Pak; 2024 May; 34(5):522-526. PubMed ID: 38720210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
    Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
    Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
    Cho HH; Choi M; Cho S; Lee JH
    J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: A prospective, comparative study.
    Xu Z; Wang C; Xing X; Zhang C; Xiang LF
    J Cosmet Dermatol; 2024 Jun; 23(6):2049-2057. PubMed ID: 38456556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials.
    Calacattawi R; Alshahrani M; Aleid M; Aleid F; Basamih K; Alsugair G; Alqahtani R; AlKhabbaz N; Algaidi Y; Alrakayan L; Almohanna A; Madkhali A; Aljohani S; Alotibi N
    J Dermatolog Treat; 2024 Dec; 35(1):2361106. PubMed ID: 38843906
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials.
    Feng X; Su H; Xie J
    J Clin Pharm Ther; 2021 Oct; 46(5):1263-1273. PubMed ID: 33959984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
    Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
    J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
    Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
    Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study.
    Chung JY; Lee JH; Lee JH
    J Dermatolog Treat; 2016 Aug; 27(4):373-7. PubMed ID: 26526300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
    Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
    J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
    Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
    Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
    Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.